Want to join the conversation?
$LVLT 2Q15 Call: North America CNS revenue grew 6.7% YoverY. In EMEA, YoverY CNS revenue declined 2.7% on a constant currency basis and 12% on an as reported basis. In Latin America, CNS revenue grew 5.7% on a constant currency basis and declined 7% on an as reported basis.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?